3-15074130-C-G
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_022340.4(RBSN):āc.2007G>Cā(p.Glu669Asp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000299 in 1,613,994 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_022340.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
RBSN | NM_022340.4 | c.2007G>C | p.Glu669Asp | missense_variant | 14/14 | ENST00000253699.7 | NP_071735.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
RBSN | ENST00000253699.7 | c.2007G>C | p.Glu669Asp | missense_variant | 14/14 | 1 | NM_022340.4 | ENSP00000253699.3 | ||
RBSN | ENST00000476527.6 | c.2007G>C | p.Glu669Asp | missense_variant | 13/13 | 2 | ENSP00000422551.1 | |||
ENSG00000289750 | ENST00000698784.1 | n.1422G>C | non_coding_transcript_exon_variant | 8/9 | ||||||
ENSG00000289750 | ENST00000698785.1 | n.2618G>C | non_coding_transcript_exon_variant | 14/17 |
Frequencies
GnomAD3 genomes AF: 0.000138 AC: 21AN: 152132Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000119 AC: 30AN: 251154Hom.: 0 AF XY: 0.000103 AC XY: 14AN XY: 135714
GnomAD4 exome AF: 0.000316 AC: 462AN: 1461862Hom.: 1 Cov.: 32 AF XY: 0.000271 AC XY: 197AN XY: 727232
GnomAD4 genome AF: 0.000138 AC: 21AN: 152132Hom.: 0 Cov.: 32 AF XY: 0.000162 AC XY: 12AN XY: 74290
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Nov 20, 2023 | The c.2007G>C (p.E669D) alteration is located in exon 14 (coding exon 11) of the RBSN gene. This alteration results from a G to C substitution at nucleotide position 2007, causing the glutamic acid (E) at amino acid position 669 to be replaced by an aspartic acid (D). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at